BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20732642)

  • 1. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel therapeutics - exciting gifts but how best to use them?
    McInnes IB; O'Dell JR
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):441-2. PubMed ID: 20732642
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory arthritis.
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):457-61. PubMed ID: 20732644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
    Boers M
    Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
    [No Abstract]   [Full Text] [Related]  

  • 5. Early intervention in rheumatoid arthritis.
    Vasanth LC; Paget SA
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis.
    Emery P; Foster W; Suarez-Almazor M
    Clin Evid; 2002 Jun; (7):1101-21. PubMed ID: 12230730
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions.
    McSweeney PA; Furst DE; West SG
    Arthritis Rheum; 1999 Nov; 42(11):2269-74. PubMed ID: 10555019
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
    Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G
    Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
    van Oosterhout M; Verburg RJ; Levarht EW; Moolenburgh JD; Barge RM; Fibbe WE; van Laar JM
    Ann Rheum Dis; 2005 Dec; 64(12):1783-5. PubMed ID: 16284342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis.
    Pavletic SZ; Klassen LW; Pope R; O'Dell JR; Traynor AE; Haire CE; Graziano F; Oyama Y; Barr W; Burt RK
    J Rheumatol Suppl; 2001 Oct; 64():28-31. PubMed ID: 11642500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis.
    Dale J; Porter D
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):443-55. PubMed ID: 20732643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of rheumatoid arthritis.
    Caldwell JR
    J Fla Med Assoc; 1995 May; 82(5):343-7. PubMed ID: 7602306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic polyarthritis].
    Frey D; Hasler P; Tyndall A
    Schweiz Med Wochenschr; 1997 Nov; 127(46):1887-900. PubMed ID: 9454312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].
    Manger B;
    Z Rheumatol; 2002 Dec; 61(6):694-7. PubMed ID: 12491133
    [No Abstract]   [Full Text] [Related]  

  • 17. [New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction].
    Perniok A; Rubbert-Roth A
    Z Rheumatol; 2003 Oct; 62(5):433-8. PubMed ID: 14579030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in the treatment of rheumatoid polyarthritis].
    So A; Dudler M
    Rev Med Suisse Romande; 2000 Jul; 120(7):577-9. PubMed ID: 10967644
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of early aggressive rheumatoid arthritis during pregnancy and lactation.
    Ostensen M
    Expert Opin Pharmacother; 2009 Jun; 10(9):1469-79. PubMed ID: 19505214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.